Physician profile
Nason Lui
NPI 1841260247
$1,134.08
in general payments reported to CMS, 2019-2025
14 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $57.14 · 2022: $457 · 2023: $99.54 · 2024: $111 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $261.62 | 2022 | |
| Canon Medical Systems USA, INC. | $200.64 | 2025 | Interventional Angiography System |
| Kci USA, INC. | $166.97 | 2019-2023 | Abthera Advance |
| Endologix LLC | $118.86 | 2022 | |
| Solventum Corporation | $110.52 | 2024 | Prevena |
| Smith+Nephew, INC. | $99.91 | 2019-2020 | |
| Acell, INC. | $44.39 | 2019 | |
| Davol INC. | $27.07 | 2019 | |
| Lemaitre Vascular, INC. | $26.98 | 2019 | |
| Aroa Biosurgery Incorporated | $20.69 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.92 | 2019 | |
| Integra Lifesciences Corporation | $18.49 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.90 | 2019 | |
| Kerecis Limited | $6.12 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nason Lui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.